A large Swedish trial finds that AI-assisted mammography detects more breast cancers and reduces future diagnosis rates compared to standard practices.
Key Details
- 1MASAI trial included more than 105,000 women in Sweden between 2021-2022.
- 2AI-supported mammography led to a 12% reduction in subsequent breast cancer diagnoses.
- 3Trial compared AI triage/detection to the standard two-radiologist double reading.
- 4AI was developed/trained on over 200,000 exams from more than 10 countries.
- 5Implementation should be cautious, with monitoring and validated AI tools.
- 6Published in The Lancet; lead author is Dr. Kristina Lång from Lund University.
Why It Matters
This is one of the first randomized controlled trials providing robust evidence that AI can enhance breast cancer screening programs, potentially improving early detection and reducing radiologist workload. These findings could accelerate responsible clinical adoption of AI in mammography.
Source
Radiology Business
Related News
•Radiology Business
GE HealthCare and RadNet Expand Global AI Mammography Partnership
GE HealthCare and RadNet are extending their partnership globally to offer AI-enhanced mammography systems.
•Radiology Business
NCCN Endorses AI Risk Tools for Breast Cancer Screening
NCCN's 2026 guidelines recommend routine integration of AI-based 5-year breast cancer risk prediction from mammograms.
•AuntMinnie
FDA Rejects Petition to Exempt Radiology AI Devices from 510(k) Review
FDA denies a petition to exempt certain radiology AI software from 510(k) review, stressing ongoing regulatory oversight.